Litcius/Paper detail

Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial

Cássia Emanuella Nóbrega Malta, Anna Clara Aragão Matos Carlos, Manuele Carine Maciel de Alencar, Eveline Fernandes Alves e Silva, Victor Bruno Caitano Nogueira, Ana Paula Negreiros Nunes Alves, Fábio Figueiredo Chaves, José Fernando Bastos de Moura, Paulo Goberlânio de Barros Silva

2021Supportive Care in Cancer20 citationsDOI

Topics & Concepts

MedicineDysgeusiaPlaceboMucositisBreast cancerInternal medicineRandomized controlled trialCancerGastroenterologySurgeryAdverse effectChemotherapyPathologyAlternative medicineOral health in cancer treatmentSalivary Gland Disorders and FunctionsLaser Applications in Dentistry and Medicine
Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial | Litcius